🟢 Echo IQ Limited is trading 3.4% up today as US growth story and FDA clearance drive recovery

Echo IQ Limited is trading 3.4% up today at $1.22, extending a steady recovery from last week’s pullback as investors refocus on the company's US growth trajectory.

• Recent 510(k) FDA clearance for the EchoSolv AS platform provides a significant catalyst for commercialization and adoption in the US market.
• Expanding partnerships, including deployments with Mount Sinai and an extended agreement with Mayo Clinic, reinforce expectations for a significant US revenue ramp.